“Purdue filed papers with the FDA, asking the agency to refuse to accept generic versions of the original formulation of OxyContin – the version the company had been selling all these years – on grounds that it was unsafe. The company said that it was voluntarily withdrawing the original formulation from the market for reasons “of safety.”
